Related Experiment Video

Updated: Jul 6, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Pneumocystis pneumonia

Laurie C D'Avignon1, Christina M Schofield, Duane R Hospenthal

  • 1Infectious Disease Service, San Antonio Military Medical Center, Fort Sam Houston, Texas 78234, USA. laurie.davignon@amedd.army.mil

Seminars in Respiratory and Critical Care Medicine
|March 28, 2008
PubMed

Insights

Pneumocystis pneumonia (PCP) remains a significant threat to immunocompromised individuals, including those with acquired immunodeficiency syndrome (AIDS). Continued research into this opportunistic fungal infection is crucial due to its persistent mortality rates and increasing incidence in diverse immunosuppressed populations.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Pneumocystis is an opportunistic fungus causing significant morbidity and mortality in immunocompromised individuals.
  • Despite advances like highly active antiretroviral therapy (HAART), Pneumocystis pneumonia (PCP) remains common in acquired immunodeficiency syndrome (AIDS) patients.
  • PCP is increasingly recognized in non-AIDS immunosuppressed populations, with potentially higher mortality rates.

Purpose of the Study:

  • To highlight the ongoing significance of Pneumocystis infections.
  • To underscore the need for continued evaluation of PCP's epidemiology, diagnosis, and treatment.
  • To address the increasing incidence and severity of PCP in various immunosuppressed groups.

Main Methods:

  • Review of existing literature on Pneumocystis infections.
  • Analysis of incidence and mortality data in AIDS and non-AIDS immunosuppressed patients.
  • Examination of evidence regarding potential reservoirs in normal hosts.

Main Results:

  • Pneumocystis remains a leading opportunistic infection in AIDS patients, with 10-20% mortality.
  • PCP incidence is rising in non-AIDS immunosuppressed populations.
  • Mortality data for non-AIDS patients with PCP is poorly defined but potentially high.

Conclusions:

  • Pneumocystis pneumonia necessitates ongoing investigation due to its persistent severity and expanding impact.
  • Further research is vital for understanding PCP epidemiology, clinical presentation, diagnosis, and treatment across all immunosuppressed groups.
  • The role of normal hosts as reservoirs requires further exploration.

More Related Videos

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.